Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Diamedica Therapeutics Inc (NQ: DMAC ) 2.220 +0.060 (+2.78%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Diamedica Therapeutics Inc < Previous 1 2 3 4 5 Next > DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024 May 08, 2024 DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results May 08, 2024 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024 May 02, 2024 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke April 17, 2024 From DiaMedica Therapeutics Inc. Via Business Wire Recap: DiaMedica Therapeutics Q4 Earnings March 19, 2024 Via Benzinga Earnings Outlook For DiaMedica Therapeutics November 10, 2023 Via Benzinga Earnings Preview: DiaMedica Therapeutics May 12, 2023 Via Benzinga DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023 March 19, 2024 DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results March 19, 2024 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference January 29, 2024 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer January 22, 2024 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results November 13, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023 November 09, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023 November 06, 2023 From DiaMedica Therapeutics Inc. Via Business Wire Earnings Scheduled For November 13, 2023 November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 25, 2023 Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning. Via InvestorPlace DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer September 12, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference September 06, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results August 14, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023 August 08, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference July 18, 2023 From DiaMedica Therapeutics Inc. Via Business Wire Three (3) Stocks Under $10 That Insiders Are Buying July 05, 2023 These small-cap names provide an opportunity that insiders are buying including deep value, growth, new technology, and AI. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence DiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement June 26, 2023 From DiaMedica Therapeutics Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023 June 22, 2023 Via Benzinga DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199 June 21, 2023 DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a Via Benzinga DiaMedica Therapeutics Announces $37.5 Million Private Placement June 21, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke June 21, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors May 30, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results May 15, 2023 From DiaMedica Therapeutics Inc. Via Business Wire DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023 May 08, 2023 From DiaMedica Therapeutics Inc. Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.